Astera Labs (NASDAQ:ALAB) Stock Price Down 8% – Here’s Why

Astera Labs, Inc. (NASDAQ:ALAB) dropped 8% during trading on Monday . The company traded as low as $378.00 and last traded at $380.0720. Approximately 547,914 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 5,618,146 shares. The stock had previously closed at $412.97.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the stock. JPMorgan Chase & Co. lifted their price target on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. Susquehanna upped their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th. Rothschild & Co Redburn began coverage on shares of Astera Labs in a research report on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective for the company. Roth Capital reaffirmed a “buy” rating and set a $275.00 price objective on shares of Astera Labs in a research report on Wednesday, May 6th. Finally, Needham & Company LLC lifted their target price on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $265.75.

Astera Labs Stock Performance

The company has a 50 day moving average of $335.76 and a 200-day moving average of $214.94. The stock has a market cap of $63.77 billion, a price-to-earnings ratio of 251.18, a price-to-earnings-growth ratio of 4.65 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. The company had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.Astera Labs’s revenue was up 93.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts anticipate that Astera Labs, Inc. will post 1.88 EPS for the current year.

Insider Activity

In related news, CEO Jitendra Mohan sold 325,693 shares of the company’s stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the sale, the chief executive officer directly owned 4,079,322 shares of the company’s stock, valued at $702,214,489.08. This represents a 7.39% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the sale, the director owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. This trade represents a 9.62% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 2,040,691 shares of company stock valued at $507,675,380. 10.40% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Astera Labs

Several institutional investors have recently modified their holdings of ALAB. Atreides Management LP raised its position in Astera Labs by 108.9% in the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after purchasing an additional 1,754,593 shares in the last quarter. Amundi grew its position in shares of Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after buying an additional 1,319,643 shares in the last quarter. Artisan Partners Limited Partnership acquired a new position in shares of Astera Labs during the fourth quarter worth about $148,980,000. Goldman Sachs Group Inc. increased its stake in shares of Astera Labs by 189.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock worth $218,419,000 after buying an additional 858,693 shares during the period. Finally, State Street Corp increased its stake in shares of Astera Labs by 32.5% during the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after buying an additional 760,358 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.